Impact of highly active antiretroviral therapy (HAART) on the clinical course of Tuberculosis (TB) in Human Immunodeficiency Virus (HIV) infected patients in a universitary hospital in Rio de Janeiro, Brazil A. P. M. Lacerda, F. C. Q. Mello, A. Ruffino-Netto, R. E. Chaisson, A. L. Kritski (Rio de Janeiro, Ribeirão Preto, Brazil; Baltimore, United States Of America)
Source: Annual Congress 2003 - Clinical features in tuberculosis - II
Session: Clinical features in tuberculosis - II Session type: Thematic Poster Session Number: 1026
Disease area: Respiratory infectionsRating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. P. M. Lacerda, F. C. Q. Mello, A. Ruffino-Netto, R. E. Chaisson, A. L. Kritski (Rio de Janeiro, Ribeirão Preto, Brazil; Baltimore, United States Of America). Impact of highly active antiretroviral therapy (HAART) on the clinical course of Tuberculosis (TB) in Human Immunodeficiency Virus (HIV) infected patients in a universitary hospital in Rio de Janeiro, Brazil. Eur Respir J 2003; 22: Suppl. 45, 1026
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Evaluation of empirical treatment of tuberculosis (TB) before and after the implementation of highly active antiretroviral therapy (HAART) in a teaching hospital (HUCFF/UFRJ), reference for acquired immunodeficiency syndrome (AIDS), in Rio de Janeiro, Source: Eur Respir J 2001; 18: Suppl. 33, 340s Year: 2001
Early negative sputum culture among patients treated for multidrug resistant tuberculosis (MDR-TB) in a government hospital in Rio de Janeiro Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014
Diagnosis of pulmonary tuberculosis using score system in children (HIV positive and negative). Rio de Janeiro, Brazil Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009
Outcomes of multidrug resistant tuberculosis (MDRTB) control in a 3-year period in a reference centre in Rio de Janeiro, Brazil Source: Eur Respir J 2004; 24: Suppl. 48, 655s Year: 2004
Clinical, immunological and epidemiological correlations of Tuberculosis / HIV Coinfection in patients Infected with HIV in Olt County in Romania between 2005-2015 Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019
Tuberculosis in human immunodeficiency virus (HIV) seropositive and seronegative populations, in a tuberculosis unit of a hospital in Lisbon Source: Eur Respir J 2001; 18: Suppl. 33, 479s Year: 2001
Risk factors for defaulting from antituberculosis treatment (RFDAT) in a community health center in Nova Iguacu - Rio de Janeiro - Brazil Source: Eur Respir J 2002; 20: Suppl. 38, 549s Year: 2002
Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy Source: Eur Respir J 2004; 24: 11-17 Year: 2004
Pattern of active pulmonary tuberculosis in human immunodeficiency virus seropositive adult patients in University College Hospital, Ibadan, Nigeria Source: Eur Respir J 2006; 28: Suppl. 50, 170s Year: 2006
HIV screening in tuberculosis patients, in the northern region of Portugal Source: International Congress 2015 – Screening strategies in TB Year: 2015
The costs of MDR/XDR tuberculosis in Barcelona (Spain): Cases treated with DOTs/DOT plus in a specialized centre Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016
Pattern of presentation of tuberculosis and the hospital prevalence of tuberculosis and human immunodeficiency virus co-infection in University College Hospital, Ibadan: a review of five years (1998–2002) Source: Eur Respir J 2006; 28: Suppl. 50, 380s Year: 2006
Tuberculosis (TB) and HIV co-infection in Romania Source: Annual Congress 2010 - Tuberculosis and HIV coinfection Year: 2010
Cost effectiveness (CE) analysis of polymerase chain reaction (PCR) for diagnosing smear negative pulmonary tuberculosis (SNPT) among inpatients in a teaching hospital, reference for AIDS and tuberculosis (TB), in Rio de Janeiro, Brazil Source: Eur Respir J 2002; 20: Suppl. 38, 582s Year: 2002
Treatment outcome among HIV positive and HIV negative TB patients in Chandigarh, India: A retrospective cohort study Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Particularities of a cohort of preXDR / XDR TB patients treated with group 5 medication, hospitalized in MDR TB Department Institute of Pneumophtisiology Bucharest, Romania Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016
Tuberculosis (TB) detection with HIV infected patients Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009
Tuberculosis & HIV patterns in a TB referral center in Iran Source: Eur Respir J 2004; 24: Suppl. 48, 197s Year: 2004
A retrospective analysis of outcome of Isoniazide preventive therapy in adults living with HIV in Penang, Malaysia Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016
Tuberculosis treatment outcomes in HIV co-infected patients in Novokuznetsk, Russian Federation Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018